Package 50090-5853-0

{"route": ["ORAL"], "spl_id": "4ed19ca8-e239-41ce-afc3-4211caa41781", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199888"], "spl_set_id": ["f7f2d1bc-9c65-4798-826f-6902b3ec81dc"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (50090-5853-0)", "package_ndc": "50090-5853-0", "marketing_start_date": "20211110"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (50090-5853-1)", "package_ndc": "50090-5853-1", "marketing_start_date": "20211110"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (50090-5853-2)", "package_ndc": "50090-5853-2", "marketing_start_date": "20211110"}], "brand_name": "topiramate", "product_id": "50090-5853_4ed19ca8-e239-41ce-afc3-4211caa41781", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "50090-5853", "generic_name": "topiramate", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA078235", "marketing_category": "ANDA", "marketing_start_date": "20090327", "listing_expiration_date": "20261231"}